Showing results (231-240 of 254) with videos related to

Sort By:
Pageof 26
Preventing Chronic Disease|December 12, 2024
Trends in Mental, Behavioral, and Developmental Disorders Among Children and Adolescents in the US, 2016-2021Rebecca T Leeb, Melissa L Danielson, Angelika H Claussen, et al.
Journal of Medicinal Chemistry|February 16, 2021
CC-90009: A Cereblon E3 Ligase Modulating Drug That Promotes Selective Degradation of GSPT1 for the Treatment of Acute Myeloid LeukemiaJoshua D Hansen, Matthew Correa, Matt Alexander, et al.
Microbiome|December 28, 2022
Alterations of oral microbiota and impact on the gut microbiome in type 1 diabetes mellitus revealed by integrated multi-omic analysesB J Kunath, O Hickl, P Queirós, et al.
Plos Biology|January 28, 2021
Why Lyme disease is common in the northern US, but rare in the south: The roles of host choice, host-seeking behavior, and tick densityHoward S Ginsberg, Graham J Hickling, Russell L Burke, et al.
Plos Biology|September 8, 2021
Correction: Why Lyme disease is common in the northern US, but rare in the south: The roles of host choice, host-seeking behavior, and tick densityHoward S Ginsberg, Graham J Hickling, Russell L Burke, et al.
Brain, Behavior, and Immunity|December 13, 2025
Resistant starch improves Parkinson's disease symptoms through restructuring of the gut microbiome and modulating inflammationViacheslav A Petrov, Sebastian Schade, Cedric C Laczny, et al.
NPJ Biofilms and Microbiomes|July 20, 2017
Comparative integrated omics: identification of key functionalities in microbial community-wide metabolic networksHugo Roume, Anna Heintz-Buschart, Emilie E L Muller, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2008
Hexahydro-pyrrolo- and hexahydro-1H-pyrido[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymeraseFrank Ruebsam, Zhongxiang Sun, Benjamin K Ayida, et al.
Arthritis Care & Research|April 17, 2013
Challenges of cardiovascular risk assessment in the routine rheumatology outpatient setting: an observational study of 110 rheumatoid arthritis patientsL Gossec, F Salejan, H Nataf, et al.
Bioorganic & Medicinal Chemistry Letters|September 18, 2008
Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 5: Exploration of pyridazinones containing 6-amino-substituentsPeter S Dragovich, Julie K Blazel, David A Ellis, et al.
Pageof 26